Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy

Author(s)

Bonezi, Vivian ; Genvigir, Fabiana Dalla Vecchia ; Salgado, Patricia de Cassia ; Felipe, Claudia Rosso ; Tedesco-Silva Jr, Helio ; Medina-Pestana, Jose Osmar ; Cerda, Alvaro ; Doi, Sonia Quateli ; Hirata, Mario Hiroyuki ; Crespo Hirata, Rosario Dominguez

• Document type: Journal article
• Source: ANNALS OF TRANSLATIONAL MEDICINE; v. 8, n. 17, p. 14-pg., 2020-09-01.

Abstract

Background: Genetic and epigenetics factors have been implicated in drug response, graft function and rejection in solid organ transplantation. Differential expression of genes involved in calcineurin and mTOR signaling pathway and regulatory miRNAs was analyzed in the peripheral blood of kidney recipient cohort (n=36) under tacrolimus-based therapy. Methods: PPP3CA, PPP3CB, MTOR, FKBP1A, FKBP1B and FKBP5 mRNA expression and polymorphisms in PPP3CA and MTOR were analyzed by qPCR. Expression of miRNAs targeting PPP3CA (miR-30a, miR-145), PPP3CB (miR-10b), MTOR (miR-99a, miR-100), and FKBP1A (miR-103a) was measured by qPCR array. Results: PPP3CA and MTOR mRNA levels were reduced in the first three months of treatment compared to pre-transplant (P<0.05). PPP3CB, FKBP1A, FKBP1B, and FKBP5 expression was not changed. In the 3rd month of treatment, the expression of miR-99a, which targets MTOR, increased compared to pre-transplant (P<0.05). PPP3CA c.249G>A (GG genotype) and MTOR c.2997C>T (TT genotype) were associated with reduced expression of PPP3CA mRNA and MTOR, respectively. FKBP1B mRNA levels were higher in patients with acute rejection (P=0.026). Conclusions: The expression of PPP3CA, MTOR and miR-99a in the peripheral blood of renal recipients is influenced by tacrolimus-based therapy and by PPP3CA and MTOR variants. These molecules can be potential biomarkers for pharmacotherapy monitoring. (AU)

• FAPESP's process: 11/10039-6 - Study of the expression and candidate gene polymorphisms of calcineurin inhibitors in renal transplant recipients
• Grantee: Rosario Dominguez Crespo Hirata
• Support Opportunities: Regular Research Grants
• FAPESP's process: 16/13118-8 - Pharmacogenomics and epigenomics factors associated with response to immunosuppressive drugs in renal transplant recipients
• Grantee: Rosario Dominguez Crespo Hirata
• Support Opportunities: Regular Research Grants